Cargando…
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
OBJECTIVES: Liver metastases occur in 45% of patients with advanced metastatic medullary thyroid cancer (MTC). Transarterial radioembolization (TARE) has been proposed to treat liver metastases (LM), especially in neuroendocrine tumors. The aim of this study was to investigate the biochemical (calci...
Autores principales: | Puleo, Luciana, Agate, Laura, Bargellini, Irene, Boni, Giuseppe, Piaggi, Paolo, Traino, Claudio, Depalo, Tommaso, Lorenzoni, Giulia, Bianchi, Francesca, Volterrani, Duccio, Brogioni, Sandra, Bottici, Valeria, Brunetto, Maurizia Rossana, Coco, Barbara, Molinaro, Eleonora, Elisei, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641787/ https://www.ncbi.nlm.nih.gov/pubmed/36126186 http://dx.doi.org/10.1530/ETJ-22-0130 |
Ejemplares similares
-
Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres
por: Depalo, Tommaso, et al.
Publicado: (2021) -
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016) -
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
por: Lorusso, L., et al.
Publicado: (2023) -
Management of Liver Tumors during the COVID-19 Pandemic: The Added Value of Selective Internal Radiation Therapy (SIRT)
por: Bargellini, Irene, et al.
Publicado: (2021) -
Transarterial radioembolization with Yttrium-90: current status and future prospects
por: Yang, Hua-Yu, et al.
Publicado: (2020)